MMRF Leadership

The people who steer the MMRF are deeply committed to curing cancer now. They have been instrumental in establishing our culture of speed, innovation and results, and continue to help accelerate the development of new and better treatments and cures. Meet them here.

There is room for innovation and efficiency to accelerate cancer research. That’s why Kathy Giusti believes in transforming how new treatments are developed across all cancers. By putting patients at the center of everything.

As Co-Chair at the Harvard Business School Kraft Precision Medicine Accelerator, Kathy is working with disruptive leaders across the cancer ecosystem to revolutionize and accelerate business models in precision medicine.

As Founder of the Multiple Myeloma Research Foundation (MMRF) and a patient herself, Kathy knows firsthand how to bring a community together to drive toward cures. It was there, at the MMRF, that Kathy first drew on her extensive experience in the pharmaceutical industry to build collaborative models and aligned incentives, always with a focus on the patient.

Kathy Giusti

Founder and Chief Mission Officer
MMRF and MMRC

There is room for innovation and efficiency to accelerate cancer research. That’s why Kathy Giusti believes in transforming how new treatments are developed across all cancers. By putting patients at the center of everything.

As Co-Chair at the Harvard Business School Kraft Precision Medicine Accelerator, Kathy is working with disruptive leaders across the cancer ecosystem to revolutionize and accelerate business models in precision medicine.

As Founder of the Multiple Myeloma Research Foundation (MMRF) and a patient herself, Kathy knows firsthand how to bring a community together to drive toward cures. It was there, at the MMRF, that Kathy first drew on her extensive experience in the pharmaceutical industry to build collaborative models and aligned incentives, always with a focus on the patient.

Learn more about Kathy.

Paul Giusti

President and Chief Executive Officer
MMRF and MMRC

Prior to the MMRF, Mr Giusti worked as a Chief Executive Officer, leader, executive and entrepreneur for more than 30 years; he has founded, managed and led a variety of businesses throughout his career. Most recently, Mr Giusti served as the Chief Executive Officer of Structural Graphics, an integrated marketing firm. Mr Giusti is also a Co-Founder and Partner in Halen Homes, a privately-held home building and real estate development company.
Mr Giusti has worked closely with the MMRF since its founding in 1998. In addition to chairing the current $100 million capital campaign, he has served as a consultant for a number of foundation projects, led several MMRF outreach efforts and spoken on behalf of the MMRF.

 

Mike Mortimer

Executive Partner and Founder
GHO Capital

Chairman of the Board
MMRF

Mike has 28 years of operating and management experience, most recently at Quintiles an Executive Vice President. In this role, Mike was responsible for Quintiles’ global operations in Health Engagement and Communications, Legal and Risk Management, Real Estate and Facilities, Human Resources as well as Security. He was also the Chairman of the company’s European, Middle East, Africa and Latin American management board, in which he was accountable for the organic and inorganic growth strategies of the regions. Mike sits on the boards of Oxford Cancer Biomarkers Ltd., HUYA Bioscience International and the Multiple Myeloma Research Foundation.

 

Lori Tauber Marcus

Founder
Courtyard Connections

Vice Chairman of the Board
MMRF

Lori Marcus is an independent board director and keynote speaker who serves as Vice Chairman of the MMRF board. Lori is also the Chairman of the board of DNA Diagnostics Center, a growing leader in private DNA testing services. She also serves as an independent Board Director for Talalay Global, a leader in the premium bedding category. Additionally, she is an independent Board Director for SHARE, a 40-year-old survivor-led organization based in New York City that provides support, information, and resources to women affected by breast and ovarian cancers. Lori also currently serves as a board advisor to several early stage companies, working closely with founders as they scale their businesses in direct-to-consumer and retail channels. In addition to her board work, Ms. Marcus chairs the Direct-to-Patient work stream as part of the Harvard Business School’s Kraft Precision Medicine Accelerator.

 

Kenneth Anderson, MD

Director
Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

Dr Anderson graduated from Johns Hopkins Medical School. He trained in internal medicine at Johns Hopkins Hospital and completed hematology, medical oncology, and tumor immunology training at the Dana-Farber Cancer Institute. Dr Anderson is the Kraft Family Professor of Medicine at Harvard Medical School and serves as Chief of the Division of Hematologic Neoplasia, Director of the Jerome Lipper Multiple Myeloma Center, and Vice Chair of the Joint Program in Transfusion Medicine at the Dana-Farber Cancer Institute. He received the Waldenstrom’s Award in 2003 for his translational research directed to the development of novel therapeutics targeting the myeloma cell in its microenvironment and is a Doris Duke Distinguished Clinical Research Scientist.

 

Karen E. Andrews

Senior Vice President and General Counsel
March of Dimes

Karen E. Andrews is currently SVP and General Counsel for the March of Dimes. Previously Karen was the General Counsel and Corporate Secretary of BBDO Worldwide, Inc. where she was responsible for the management of the legal activities of over 150 individual operating units throughout the world. Prior to joining BBDO Worldwide, Ms. Andrews was Associate General Counsel and Director of Television Business Affairs at Time Inc. Ms. Andrews began her career in law as a Litigation Associate at the New York law firm of Weil, Gotshal & Manges where she specialized in Entertainment Litigation.

 

Thomas Conheeney

Retired President
SAC Capital

Tom was appointed President of SAC Capital in July 2008. He joined SAC in October 1999 as Chief Operating Officer. Prior to joining SAC, Tom was President of Investment Management Services, Inc (“IMS”) from 1996 to 1999. He joined Moore Capital /IMS in 1993 and served as its Director of Trading Operations and then Vice President until IMS split off from Moore in 1995. He retired from SAC December 2014.

 

David L. Lucchino

Co-Founder, President and Chief Executive Officer
Frequency Therapeutics

David Lucchino is an entrepreneur and business leader in the world’s leading life science cluster, the Kendall Square district of Cambridge, Massachusetts.

David is co-founder and CEO of Frequency Therapeutics, a clinical-stage, venture-backed company that is advancing a novel way to enlist the body’s native regenerative abilities to treat chronic conditions, including noise-induced hearing loss and diseases of the skin, muscles and gastrointestinal tract.

David is the Chairman of the Board of Directors of MassBio, the voice of the biotechnology industry in Massachusetts representing more than 1,100 companies as well hospitals, research labs and other organizations.

David has a long track record of success as an entrepreneur. He was co-founder and CEO of Semprus BioSciences, a medical device firm that earned numerous FDA clearances and was acquired by a public medical device firm in an $80 million transaction. He also was the CEO of Entrega Bio, which is developing an oral delivery mechanism for therapeutics typically administered by injection or infusion.

David worked at Polaris Partners, the influential venture capital firm that has funded numerous life sciences companies. He started his biotech career as a co-founder and managing director of LaunchCyte, a firm that acquired biomedical intellectual property and built companies around those discoveries.

Mr. Lucchino is a member of the College of Fellows of the American Institute for Medical and Biological Engineering and was appointed by Governor Charlie Baker as a member of the Advisory Council to the Massachusetts Department of Labor Relations.

Mr. Lucchino serves as a trustee of Mt. Auburn Hospital in Cambridge, MA; a trustee of the Multiple Myeloma Research Foundation; a member of the Board of Advisors for Life Science Cares; and a member of the Board of Advisors for NOLS, which teaches leadership skills through wilderness experiences. He was part of a NOLS expedition that climbed Denali in Alaska.

Mr. Lucchino earned a B.A. from Denison University, an M.S. from the Newhouse School of Journalism at Syracuse University, and an M.B.A. from the MIT Sloan School of Management. He lives in Boston’s Charlestown neighborhood with his wife, son and two dogs

 

Dana LaForge

Partner
Brera Capital Partners, LLC

Dana LaForge is a Partner at Brera Capital Partners, a private equity fund, and the Founder and Managing Partner of Colonnade Financial Group, a private equity services firm. Prior to Brera and Colonnade, Dana was head of Financial Institutions Investment Banking and Chief of Staff of Banking and Capital Markets at Deutsche Bank and its predecessor companies. Earlier in his career, he was a bond trader and founded the Mortgage Finance Group. Dana has served on numerous portfolio company boards and is the Chairman of GAB Robins NA.

 

Susan Marvin

Vice Chair
Marvin Windows and Doors

Susan Marvin serves as Vice Chair of The Marvin Companies and is a member of the company’s Executive Steering Committee. She has been part of the third generation management team and is one of 14 third and fourth generation Marvin family members operating the company today. Active in both profit and nonprofit boards, Susan serves on The Marvin Companies Board of Directors, M. A. Mortenson Company Board of Directors, the Harvard University Joint Center for Housing Studies Policy Advisory Board Executive Committee, the National Association of Manufacturers Board of Directors, the Minneapolis Institute of Art Board of Trustees, and the University of Minnesota Foundation Board of Trustees. She is a member of the World Presidents’ Organization (WPO).

 

Gerald McDougall

Partner
PricewaterhouseCoopers LLP

Mr. McDougall is Partner at PricewaterhouseCoopers Health Sciences Practice, where he provides services to academic medical centers, bioscience companies, pharmaceutical companies, research universities, colleges, health systems, and other research organizations. His practice provides a broad range of research business and compliance services, including strategic and business planning, financial analysis, research compliance, clinical research operations improvement, and information systems implementation services.

 

William S. McKiernan

Former Chair and CEO
CyberSource Corporation

William McKiernan is the Chairman and Chief Executive Officer of CyberSource Corporation. Prior to founding CyberSource, Mr. McKiernan was President and Chief Operating Officer of McAfee Associates, now Network Associates; Mr. McKiernan held this position during the company’s initial public offering. Before joining McAfee, Mr. McKiernan was Vice President of Princeton Venture Research, Inc. and held management positions at ROLM/IBM. In addition to serving on the Board of Directors of the MMRF, Mr. McKiernan is the West Coast Chairman of the Boston College Technology Council.

 

David R. Parkinson, MD

Chairman of the Clinical Advisory Board
Zyngenia. Inc.

From 2007 until 2012, Dr Parkinson served as President and CEO of Nodality, a South San Francisco-based venture-financed biotechnology company developing technologies to enable personalized medicine and more efficient drug development in cancer and autoimmune diseases. Before joining Nodality, Dr Parkinson was Senior Vice President, Oncology R&D, at Biogen Idec, overseeing oncology discovery research efforts and the development of the oncology pipeline. Previously he had served tenures as Vice President and Head of the Oncology Therapeutic Area at Amgen and Vice President and Head of Global Clinical Oncology Development at Novartis.

 

Marie Pinizzotto, MD

President and CEO
Carol A. Ammon Foundation

Marie Pinizzotto, M.D., MBA, is currently the president and CEO of the Carol A. Ammon Foundation, a foundation focused on health care, education and children with disabilities. She was also the president of Drug Safety Solutions, L.L.C., a Pharmacovigilance and Risk Management consulting company whose main focus is pharmacovigilance and risk management for narcotics and other high risk drugs. Prior to starting her consulting firm she worked at Endo Pharmaceuticals Inc. where she was Senior Director of the Global Safety and Pharmacovigilance department. In this role she was responsible for pharmacovigilance of all Endo products, investigational as well as marketed. Marie was responsible for the safety components in following disciplines as well; Clinical Research, Medical Affairs and Clinical Education and Development.

 

Michael Reinert

Partner
Fox Rothschild LLP

Michael Reinert is a leading music industry attorney who most recently served as Executive Vice President of Business & Legal Affairs for the Universal Motown Republic Group, a division of UMG Recordings, Inc. In that position, he had the pleasure of working with great talent such as Stevie Wonder, Elton John, Taylor Swift, Amy Winehouse, Lil Wayne, Nelly, Jack Johnson and many other platinum selling acts. Prior to joining Universal ten years ago, Michael was the Vice President of Business & Legal Affairs for PolyGram Records, handling those duties for the legendary Verve Records label and Mercury Nashville Records where he worked with the likes of Herbie Hancock and Shania Twain.

 

Rodger Riney

Former CEO and Founder
Scottrade

Rodger Riney grew up in Kirkwood, Missouri, and graduated from the University of Missouri with a Civil Engineering degree and an MBA. In 1969, he joined Edward D. Jones & Co. in Saint Louis and later became a partner. In 1980, he left to enter the relatively new discount brokerage industry by starting Scottrade. Over the years, Scottrade has evolved into an online brokerage and bank supporting its 3 million clients through 500 branch offices nationwide.

 

Steven Shak, MD

Co-Founder, Chief Scientific Officer
Genomic Health

Dedicated to optimizing cancer treatment outcomes and bringing the patient voice into product development, Steve Shak, M.D. has served as the Co-Founder, Chief Scientific Officer since 2012 and was the Chief Medical Officer from 2000 – 2013. Under Steve’s leadership Genomic Health used innovative molecular diagnostic methods and rigorous clinical studies to develop the Oncotype DX® breast cancer and colon cancer assays and has maintained an 80% product development success rate. Steve has been a leader in personalized medicine for more than two decades.

 

Meryl Zausner

Chief Financial Officer
Novartis Corporation

Meryl Zausner has over 35 years of management experience across the pharmaceutical and consumer products industries. Meryl was instrumental in creating the blueprint for the successful Novartis Oncology Business Unit and engineering the launch of the first Novartis shared services organization. A recognized developer of diverse talent, The Healthcare Businesswomen Association honored Meryl with its prestigious Woman of Year Award.


Executive Committee

Paul Giusti
President and Chief Executive Officer
Rob Miani
Chief Financial Officer
Daniel Auclair, PhD
Senior Vice President of Research
Laura Gilman
Vice President of Events
Chris Williams
Vice President of Business Development
Anne Quinn Young, MPH
Senior Vice President, Marketing & Communications

Honorary Board

Dusty Baker
Manager, Washington Nationals and Former MLB Player
Don Baylor
Former Major League Baseball Manager and Player
James T. Brown
Host, “The NFL Today” on CBS
Host, “Thursday Night Football” on CBS
Special Correspondent, CBS News
Bob Costas
NBC and MLBN Broadcaster
Katie Couric
Global Anchor
Yahoo News
Award-winning Journalist
Cancer Advocate
Author
Cindy Crawford
Model and Spokesperson
Ann Curry
News Journalist
Clive J. Davis
Chief Creative Officer, Sony Music Entertainment
CeeLo Green
Grammy Award-Winning Singer, Songwriter and Record Producer
Scott Hamilton
Olympic Figure Skating Champion
Speaker, Author, Commentator
Mariska Hargitay
Actress
Lou Holtz
Legendary Football Coach and Analyst, ESPN
Bonnie Hunt
Actress, Director, Producer and Writer
Senator Kay Bailey Hutchison
Former United States Senator, Texas
Dan Jansen
Olympic Speed Skater
Hoda Kotb
News Anchor, Co-Host, Fourth Hour of “Today”
Diana Krall
Pianist and Singer
Sugar Ray Leonard
Boxing Legend, Entrepreneur and Author
Tara Lipinski
Olympic Figure Skating Champion
NBC Broadcaster
Wynton Marsalis
Musician, Composer, Educator
Managing and Artistic Director, Jazz at Lincoln Center
Marlee Matlin
Academy Award Winning Actress & Activist
Eric McCormack
Actor, Producer, and Writer
Deborah Norville
Inside Edition Anchor and Author
Sharon Osbourne
Music Manager and Talk Show Host
Carl Quintanilla
CNBC Anchor
Correspondent, HBO’s “Real Sports with Bryant Gumbel”
Al Roker
Weather and Features Reporter
NBC News and The Today Show
Mel Stottlemyre
Former Major League Baseball Player and Coach
Brian Williams
MSNBC Daytime Breaking-News Anchor
Pat Williams
Co-Founder and Senior Vice President, Orlando Magic
Bob Woodruff
ABC News Journalist, Anchor
Lee Woodruff
Best-selling Author

Leadership Council

Stephen Grand

President and Partner
Grand-Sakwa Properties
Lester B. Knight
Founding and Managing Partner

RoundTable Healthcare Partners
Philip J. Purcell
President

Continental Investors
Robert Wolf
President & Chief Operation Officer
UBS Investment Bank
Chairman & CEO
UBS Group Americas
MemberUBS Group Executive Board
MemberUBS Group Managing Board
Member